✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
591daili 济南圣和化工
Home › Product Catalog › Deucravacitinib (BMS-986165)

Deucravacitinib (BMS-986165)

CAS 1609392-27-9C20H22N8O3MW 425.5

Deucravacitinib (BMS-986165) (CAS No. 1609392-27-9) is supplied by Jinan Shenghe Chemical Co., Ltd. with a typical purity of 按批次COA提供(不公开发布). Main applications include Pharmaceutical Intermediates & APIs；Pharmaceutical Raw Materials. Bulk quantities are available with COA; purity and packaging are subject to batch COA and order confirmation.

Specifications

CAS Number1609392-27-9
Molecular FormulaC20H22N8O3
Molecular Weight425.5
LogP1.2
Purity按批次COA提供(不公开发布)
Packaging按订单/批次确认(不公开发布)
ApplicationsPharmaceutical Intermediates & APIs；Pharmaceutical Raw Materials
CategoryPharmaceutical Intermediates & APIs|Pharmaceutical Raw Materials

Where it is used

Pharmaceutical Intermediates & APIs；Pharmaceutical Raw Materials

Packaging & Supply

Packaging按订单/批次确认(不公开发布)
Purity按批次COA提供(不公开发布)
StorageSealed, cool and dry place
Lead TimeIn stock / per order

Documents & Support

COA provided with every batch; MSDS and technical documents available on request. Email us with product name and CAS number for a quote within one business day.

Frequently Asked Questions

What is the CAS number of Deucravacitinib (BMS-986165)?

The CAS number of Deucravacitinib (BMS-986165) is 1609392-27-9.

What purity and packaging are available?

Typical purity is 按批次COA提供(不公开发布), supplied in 按订单/批次确认(不公开发布), with COA provided.

What are the applications of Deucravacitinib (BMS-986165)?

Main applications include Pharmaceutical Intermediates & APIs；Pharmaceutical Raw Materials.

How do I buy Deucravacitinib (BMS-986165) or get a quote?

Email info@591daili.com or reach us on WhatsApp with the product name, CAS number and required quantity; quotes within one business day. Supplier: Jinan Shenghe Chemical Co., Ltd..

PubChem Public Data

Description

Deucravacitinib (BMS-986165) · CAS 1609392-27-9 · C20H22N8O3. UNII N0A21N6RAU.

Identification

CAS Registry Number1609392-27-9
PubChem CID134821691
Molecular formulaC20H22N8O3
IUPAC name6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
UNII (FDA)N0A21N6RAU

Computed Descriptors

Molecular Weight425.5
XLogP31.2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count7
Exact Mass425.20031683
Monoisotopic Mass425.20031683
Topological Polar Surface Area136
Heavy Atom Count31
Formal Charge0

Regulatory Status

GHS notification summary33.3% (1 / 3)

GHS Hazard Classification

GHS notification summary33.3% (1 / 3)
Reported hazard statementsH361 (33.3%), H372 (66.7%)

This chemical does not meet GHS hazard criteria for 33.3% (1 of 3) of reports.

H361 (33.3%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

Documented Uses

  • Deucravacitinib is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is not recommended for use in combination with other potent immunosuppressants. It is also indicated for the treatment of psoriatic arthritis in adults.
  • Deucravacitinib is a small molecule inhibitor of tyrosine kinase 2 that is used in the treatment of moderate-to-severe plaque psoriasis. Deucravacitinib is associated with transient and usually mild elevations in serum aminotransferase levels during therapy but has not been linked instances of clinically apparent acute liver injury.
  • Breast Feeding; Lactation; Milk, Human; Dermatologic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Tyrosine Kinase Inhibitors; Signal Transduction Inhibitors; Janus Kinase Inhibitors; JAK Inhibitors
  • Take with or without food. Food has no clinically significant effect on drug absorption and exposure.
  • Drugs used to treat or prevent skin disorders or for the routine care of skin.
  • Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.

Synonyms

Deucravacitinib; 1609392-27-9; BMS-986165; Sotyktu; N0A21N6RAU; RefChem:58358; Tyk2-IN-4; BMS986165; Deucravacitinib [USAN]; MFCD31715455; Deucravacitinib (BMS-986165); Tyk2-IN-4(BMS986165); bms 986165; Sotyktu (TN); Deucravacitinib [MI]; UNII-N0A21N6RAU

Frequently Asked Questions

What are the CAS number and molecular formula of Deucravacitinib (BMS-986165)?

CAS 1609392-27-9; molecular formula C20H22N8O3; molecular weight — g/mol.

What other names is Deucravacitinib (BMS-986165) known by?

Deucravacitinib, 1609392-27-9, BMS-986165, Sotyktu, N0A21N6RAU, RefChem:58358.

Is Deucravacitinib (BMS-986165) classified as hazardous?

33.3% of GHS notifications report no hazard classification (1 of 3).

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

You may also need

acycloguanosineCAS 59277-89-3›
AtenololCAS 29122-68-7›
AcetamideCAS 60-35-5›
AdenineCAS 73-24-5›
AmpicillinCAS 69-53-4›
AzithromycinCAS 83905-01-5›
Amoxicillin trihydrateCAS 61336-70-7›
Atorvastatin CalciumCAS 134523-03-8›

Get a quote for Deucravacitinib (BMS-986165)

Supplier: Jinan Shenghe Chemical Co., Ltd. · Reply within one business day.

Email Inquiry WhatsApp
鲁ICP备19031700号-1